CN105435026A - Medicine for treating arrhythmia - Google Patents

Medicine for treating arrhythmia Download PDF

Info

Publication number
CN105435026A
CN105435026A CN201610048498.8A CN201610048498A CN105435026A CN 105435026 A CN105435026 A CN 105435026A CN 201610048498 A CN201610048498 A CN 201610048498A CN 105435026 A CN105435026 A CN 105435026A
Authority
CN
China
Prior art keywords
parts
medicine
herba
heart
arrhythmia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610048498.8A
Other languages
Chinese (zh)
Inventor
陈锦清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610048498.8A priority Critical patent/CN105435026A/en
Publication of CN105435026A publication Critical patent/CN105435026A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/902—Sparganiaceae (Bur-reed family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating the arrhythmia. The medicine is prepared from, by weight, 10 parts of poria with hostwood, 5 parts of asarum, 18 parts of Chinese pyrola herb, 12 parts of cistanche salsa, 7 parts of rhizoma sparganic, 10 parts of ligustrum lucidum ait, 8 parts of finger citron and 7 parts of dichroae radix. The medicine has the advantages that poria with hostwood quiets heart, soothes nerves and promotes urination; asarum dispels cold and wind, stops pain and dredges orifices, and warms lung and dissipates excessive fluid; Chinese pyrola herb nourishes kidney and strengthens bones, dispels wind and eliminates dampness, and stops coughing and bleeding; cistanche salsa nourishes kidney yang, nourishes body fluid and blood, and lubricates intestines; rhizoma sparganic removes blood stasis and promotes qi circulation, and eliminates stasis and stops pain; ligustrum lucidum ait nourishes liver and kidney, clears away deficiency heat and improves eyesight; finger citron discharges liver and regulates qi, and harmonizes stomach and stops pain; dichroae radix removes phlegm and eliminates dampness; the medicine components are used in cooperation and have functions of nourishing yin and clearing away fever, tranquilizing mind by nourishing heart, promoting blood circulation to remove blood stasis and regulating qi and dredging veins; it is proved through clinical experiments that the medicine can safely and effectively treat the arrhythmia.

Description

One is used for the treatment of ARR medicine
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to one and be used for the treatment of ARR medicine.
Background technology
Arrhythmia (arrhythmia) refers to that the cardiac impulse that any cause of disease causes is formed and/or conduction abnormalities; because the exciting exception of sinuatrial node or excitement result from beyond sinuatrial node; exciting conduction slowly, retardance or through abnormal passage conduction, namely the origin of cardiomotility and (or) conductive impairment cause frequency and (or) the allorhythmia of heartbeat.Arrhythmia is one group of disease important in cardiovascular disease.Rest sense, uncomfortable in chest, weak, dizzy with cardiopalmus, heart beating, very then faint, electrocardiogram points out various arrhythmia to be main clinical characteristics.All kinds of premature beat, paroxysm supraventricular or ventricular tachycardia, atrial fibrillation, atrioventricular block, sick sinus syndrome etc. are ARR clinical common type.It can be fallen ill separately, also can occur together with other cardiovascular diseasess.Arrhythmia is found in normal person, but is more common in greatly organic heart disease patient, as coronary heart disease, myocarditis, cardiomyopathy, rheumatic heart disease, hypertensive cardiopathy, heart failure etc., and the drug intoxication such as Folium Digitalis Purpureae, quinidine.Bring out ARR reason to comprise the idiomuscular change of the heart, electrolyte disturbance, anoxia, excited, smoking, drink strong tea etc.Its prognosis with the ARR cause of disease, inducement, evolving trend, whether cause serious hemodynamic obstacle relevant, can break out and cause sudden death, also sustainablely involve heart and cause its exhaustion.Arrhythmia belongs to the category such as " palpitation with fear ", " palpitation with a distress feeling ", " faintness ", " asthenia " of the traditional Chinese medical science.
The cause of disease
Heritability arrhythmia mostly is caused by Gene channel sudden change, as long QT syndrome, Short QT syndiome, Brugada syndrome etc.
Acquired arrhythmia will be found in various organic heart disease the day after tomorrow, wherein with coronary atherosclerotic heart disease (abbreviation coronary heart disease), cardiomyopathy, myocarditis and rheumatic heart disease (abbreviation rheumatic heart disease) for common, especially occur heart failure or acute myocardial infarction time.Occur in that arrhythmia in basic healthy person or autonomic nervous dysfunction patient is quite a few sees.Other causes of disease still have electrolyte or endocrine disturbance, anesthesia, low temperature, thoracic cavity or operation on heart, drug effect and central nervous system disease etc., part etiology unknown.
Clinical manifestation
The clinical manifestation of ARR hemodynamic change depends primarily on ARR character, type, cardiac function and the degree to hemodynamic effect, as slight sinus bradycardia, arrhythmia, accidental atrial premature beat, first degree A-V blocks etc. are very little to hemodynamic effect, therefore without obvious clinical manifestation, more serious arrhythmia, as sick sinus syndrome, rapid atrial fibrillation, paroxysmal supraventricular tachycardia, sustained ventricular tachycardia etc., cardiopalmus can be caused, breast is vexed, dizzy, hypotension, perspire, fainting can appear in severe patient, Adams Stokes syndrome, even die suddenly, because ARR type is different, clinical manifestation is different, mainly contain following several performance:
1. the performance of coronary insufficiency
Various arrhythmia all can cause coronary artery blood flow to reduce, although various arrhythmia can cause coronary flow to reduce, but lessly cause myocardial ischemia, but, to the patient having coronary heart disease, various arrhythmia can be brought out or be increased the weight of myocardial ischemia, main manifestations is angina pectoris, breathes hard, peripheral vessels exhaustion, acute heart failure, acute myocardial infarction etc.
2. the performance of cerebral arterial insufficiency
Different arrhythmia is also different on the impact of cerebral blood flow.The normal person of cerebrovascular, above-mentioned hemodynamic obstacle is unlikely causes serious consequence, if during cerebrovascular generation pathological changes, then be enough to cause cerebral blood supply insufficiency, it shows as dizziness, weak, blurred vision, temporary total blindness, the transient or permanent cerebral lesion performance such as aphasia, paralysis, tic, stupor even.
3. the performance of renal artery blood supply insufficiency
After arrhythmia occurs, also there is different minimizings in renal blood flow, clinical manifestation has oliguria, albuminuria, azotemia etc.
4. the performance of Mesenteric artery blood supply insufficiency
During tachy-arrhythmia, blood flow reduces, and Mesenteric artery spasm, can produce the clinical manifestation of gastrointestinal ischemia, and as abdominal distention, stomachache, diarrhoea, even occurs hemorrhage, ulcer or paralysis.
5. the performance of cardiac insufficiency
Be mainly cough, dyspnea, asthenia, weak etc.
Drug therapy
1. I class and sodium channel blocade, I category-A appropriateness block sodium channels, what belong to this type of has the medicines such as quinidine; The slight block sodium channels of I category-B, what belong to this type of has the medicines such as lignocaine; The obvious block sodium channels of I C class, what belong to this type of has the medicines such as Propafenone.2. II class is beta-adrenoceptor blocking drug, and because blocking beta receptor effectively, representative drugs is Propranolol.3. III class is the medicine selectively extending process of repolarization, and what belong to this type of has amiodarone.4. IV class and calcium channel blocker, their block calcium channel and suppress to flow in Ca, and representative medicine has verapamil.Long-term taking anti-arrhythmic all has side effect in various degree, serious caused ventricular arrhythmia or heart block and fatal.5. treatment by Chinese herbs, available traditional Chinese medical herbal treatment, from many aspects relief of symptoms, effectiveness comparison is desirable.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide one and is used for the treatment of ARR medicine, by selecting suitable medical material and proportioning thereof, reaches the ARR object of safe and effective healing.
In order to achieve the above object, the present invention is by the following technical solutions:
One is used for the treatment of ARR medicine, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Poria cum Radix Pini 10 parts, Herba Asari 5 parts, Herba Pyrolae 18 parts, Herba Cistanches 12 parts, Rhizoma Sparganii 7 parts, Fructus Ligustri Lucidi 10 parts, Fructus Citri Sarcodactylis 8 parts, Radix Dichroae 7 parts.
Below in conjunction with theories of Chinese materia medica, beneficial effect of the present invention is described:
Inventor thinks, the ARR cause of disease is the people of timidness due to deficiency of the heart, suddenly frightened, or element accumulates expectorant heat, is added with depressed rage impairing the liver; Or serious disease prolonged illness, involve heart spleen kidney, undermine negative and positive of qi and blood, all cause the heart and lose peace and support, mind disturbance, or heart arteries and veins stasis blocking and making up one's mind is throbbed with fear.Pathological change is the people of timidness due to deficiency of the heart, suddenly frightened, or emotion rage, large excessive fear impairing the kidney, rage impairing liver, probably then essence but, anger is QI rising in reverse order then, the deficiency of YIN under, fire is inverse in upper, then dynamicly shake the mind and make up one's mind cool.Element accumulates expectorant heat, and be added with disgruntled, stomach-QI being unable to descend normally, phlegm-fire is tied mutually, disturbing the mind upwards, also makes up one's mind and throbs with fear.Prolonged illness serious disease, damage heart spleen kidney, injures negative and positive of qi and blood.Deficiency of both the heart and spleen, deficiency of both QI and blood, the heart is become homeless foster, and the mind is disturbed; Or deficiency of kidney yin, the not good fire of water, heart-fire is solely high, the disturbance mind; Or deficiency of heart-YANG and kidney-YANG, the heart loses replenishing vital QI with drugs of warm nature, and fluid-retention stagnating in the interior, upper Ling Yuxin, all causes cardiopalmus.The stagnation of QI or the deficiency of vital energy, often make stagnation of heart-blood, and the heart is become homeless foster, also makes up one's mind and throb with fear.Therefore treatment then takes removing heat-phlegm, vigorate qi and replenish the blood, tranquilizing the mind.
The present invention uses: Poria cum Radix Pini's mind tranquilizing and the heart calming, diuretic; Herba Asari cold expelling dispels the wind, and pain relieving is sensible, warming the lung to resolve fluid-retention; Herba Pyrolae the kidney invigorating bone strengthening, expelling wind and removing dampness, cough-relieving is stopped blooding; Herba Cistanches kidney-replenishing, benefiting essence-blood, intestine moistening road; The circulation of qi promoting of Rhizoma Sparganii removing blood stasis, removing food stagnancy pain relieving; Fructus Ligustri Lucidi liver and kidney tonifying, clearind deficient heat, improving eyesight; Fructus Citri Sarcodactylis liver-smoothing, qi-regulating, and stomach and alleviating pain; Radix Dichroae robs expectorant removing dampness.All medicines share, and reach nourishing YIN and clearing away fire, tranquilizing by nourishing the heart, blood circulation promoting and blood stasis dispelling, effect of promoting blood circulation of regulating the flow of vital energy.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects 112 routine patients with arrhythmia between in February ,-2015 in March, 2012 altogether.Be divided at random: treatment group 56 example, matched group 56 example.Wherein treatment group man 26 example, female 30 example, 42 ~ 68 years old age, the course of disease 2 months ~ 5 years; Matched group man 22 example, female 34 example, between 43 ~ 65 years old age, the course of disease 4 months ~ 5 years.The data there was no significant differences such as two groups of sexes, age, courses of disease, have comparability.
Diagnostic criteria
1. have ARR medical history more, and/or have cardiopathic diagnosis medical history, and onset patient must do to check further and make a definite diagnosis.
2. clinical main manifestations: cardiopalmus, pareordia are uncomfortable, heart beating rests sense, uncomfortable in chest, weak, dizzy, very then faints.Cardiac auscultation audible and heart rate or rhythm abnormality, several slow or slow, or have premature beat, or have and close a business.Pulse Chang Chengjie, generation, short, disease, slow, several, heavy, puckery etc.
3. lab testing: electrocardiogram or ambulatory electrocardiogram all can show the abnormal indication of cardiac arrhythmia.
1. inclusive criteria meets diagnostic criteria; 2. 18 ~ 70 years old age; 3. compliance is good; 4. Informed Consent Form is signed voluntarily.
1. exclusion standard merges other serious diseases of cardiovascular system patient; 2. severe cardiac, lung, liver, renal disease patient is suffered from; 3. spiritedness systemic disease, can not partner treatment person; 4. through the patient of other drug treatment after falling ill.
2, Therapeutic Method
The capsule that the oral the present invention for the treatment of group obtains according to specific embodiment 3, every day 3 times.Treat 1 month.
The oral propafenon tablet of matched group, each 150mg, every day 3 times.Treat 1 month.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
1. fully recover: cardiopalmus symptom all disappears, electrocardiogram or dynamic ecg recordings examination recover normal, and premature beat disappears;
2. effective: symptom major part disappears, and electrocardiogram or dynamic ecg recordings examination are improved, and premature beat number of times comparatively treats front reduction;
3. invalid: above-mentioned symptom is without improvement or increase the weight of.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
Visible, the medicine that the present invention obtains can safe and effective treatment arrhythmia, and cure rate is high.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Poria cum Radix Pini 10 grams, Herba Asari 5 grams, Herba Pyrolae 18 grams, Herba Cistanches 12 grams, Rhizoma Sparganii 7 grams, Fructus Ligustri Lucidi 10 grams, Fructus Citri Sarcodactylis 8 grams, Radix Dichroae 7 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of arrhythmia.Oral, daily once.
Embodiment 2
Take: Poria cum Radix Pini 10 grams, Herba Asari 5 grams, Herba Pyrolae 18 grams, Herba Cistanches 12 grams, Rhizoma Sparganii 7 grams, Fructus Ligustri Lucidi 10 grams, Fructus Citri Sarcodactylis 8 grams, Radix Dichroae 7 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of arrhythmia.Oral, every bu is taken for twice sooner or later.
Embodiment 3
Take: Poria cum Radix Pini 10 grams, Herba Asari 5 grams, Herba Pyrolae 18 grams, Herba Cistanches 12 grams, Rhizoma Sparganii 7 grams, Fructus Ligustri Lucidi 10 grams, Fructus Citri Sarcodactylis 8 grams, Radix Dichroae 7 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of arrhythmia.Oral, every bu morning, noon and afternoon take for three times.

Claims (4)

1. one kind is used for the treatment of ARR medicine, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Poria cum Radix Pini 10 parts, Herba Asari 5 parts, Herba Pyrolae 18 parts, Herba Cistanches 12 parts, Rhizoma Sparganii 7 parts, Fructus Ligustri Lucidi 10 parts, Fructus Citri Sarcodactylis 8 parts, Radix Dichroae 7 parts.
2. one as claimed in claim 1 is used for the treatment of ARR medicine, and it is characterized in that, its preparation method is: take: Poria cum Radix Pini 10 parts, Herba Asari 5 parts, Herba Pyrolae 18 parts, Herba Cistanches 12 parts, Rhizoma Sparganii 7 parts, Fructus Ligustri Lucidi 10 parts, Fructus Citri Sarcodactylis 8 parts, Radix Dichroae 7 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. one as claimed in claim 1 is used for the treatment of ARR medicine, and it is characterized in that, its preparation method is: take: Poria cum Radix Pini 10 parts, Herba Asari 5 parts, Herba Pyrolae 18 parts, Herba Cistanches 12 parts, Rhizoma Sparganii 7 parts, Fructus Ligustri Lucidi 10 parts, Fructus Citri Sarcodactylis 8 parts, Radix Dichroae 7 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. one as claimed in claim 1 is used for the treatment of ARR medicine, and it is characterized in that, its preparation method is: take: Poria cum Radix Pini 10 parts, Herba Asari 5 parts, Herba Pyrolae 18 parts, Herba Cistanches 12 parts, Rhizoma Sparganii 7 parts, Fructus Ligustri Lucidi 10 parts, Fructus Citri Sarcodactylis 8 parts, Radix Dichroae 7 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
CN201610048498.8A 2016-01-25 2016-01-25 Medicine for treating arrhythmia Withdrawn CN105435026A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610048498.8A CN105435026A (en) 2016-01-25 2016-01-25 Medicine for treating arrhythmia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610048498.8A CN105435026A (en) 2016-01-25 2016-01-25 Medicine for treating arrhythmia

Publications (1)

Publication Number Publication Date
CN105435026A true CN105435026A (en) 2016-03-30

Family

ID=55545951

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610048498.8A Withdrawn CN105435026A (en) 2016-01-25 2016-01-25 Medicine for treating arrhythmia

Country Status (1)

Country Link
CN (1) CN105435026A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784865A (en) * 2012-12-18 2014-05-14 唐继元 Chinese herbal medicine for treating palpitation due to insufficiency heart qi, deficiency of yin and stagnation of liver qi
CN104758582A (en) * 2015-03-11 2015-07-08 兰柳生 Traditional Chinese medicine composition for treating arrhythmia in the type of fire excess from yin deficiency
CN104873689A (en) * 2015-06-17 2015-09-02 孙宗丽 Chinese medicinal composition for treating cardiovascular diseases
CN104984207A (en) * 2015-07-22 2015-10-21 王丹丹 Medicine for treating heart-yang deficiency type arrhythmia

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784865A (en) * 2012-12-18 2014-05-14 唐继元 Chinese herbal medicine for treating palpitation due to insufficiency heart qi, deficiency of yin and stagnation of liver qi
CN104758582A (en) * 2015-03-11 2015-07-08 兰柳生 Traditional Chinese medicine composition for treating arrhythmia in the type of fire excess from yin deficiency
CN104873689A (en) * 2015-06-17 2015-09-02 孙宗丽 Chinese medicinal composition for treating cardiovascular diseases
CN104984207A (en) * 2015-07-22 2015-10-21 王丹丹 Medicine for treating heart-yang deficiency type arrhythmia

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘永昌: "《新编心脑血管疾病中西医治疗》", 31 December 1996, 中国中医药出版社 *
张胜杰: "《冠心病》", 31 July 2015, 中国医药科技出版社 *
肖小河等: "《中国军事本草》", 31 July 2012, 人民军医出版社 *
陈会娟等: "郭维琴教授缓慢性心律失常治疗经验", 《环球中医药》 *

Similar Documents

Publication Publication Date Title
CN103202879A (en) Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof
CN104958490A (en) Medicine for treating qi stagnation and blood stasis type coronary heart diseases and method for manufacturing medicine
CN1030183A (en) A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use
CN103041134B (en) Traditional Chinese medicine composition for treating vital myocarditis
CN102048939B (en) Medicament for treating sinus bradycardia
CN100386112C (en) Arrhythmia treating Chinese medicine prepn and its prepn process
CN104147346A (en) Traditional Chinese medicinal compound for treating coronary diffuse lesion angina
CN103933280A (en) Traditional Chinese medicine composition for treating PCI (percutanecus coronary intervention) postoperative angina of phlegm-obstructing heart vessel type coronary heart disease and application thereof
CN105435026A (en) Medicine for treating arrhythmia
CN111529659A (en) Traditional Chinese medicine composition for treating bradyarrhythmia and preparation method and application thereof
CN102861169B (en) Traditional Chinese medicine compound for treating paroxysmal supraventricular tachycardia
CN105832978A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN102579804B (en) Chinese medicine for treating stenocardia
CN103800723B (en) One is used for the treatment of ARR Chinese medicine composition and preparation method thereof
CN101176743B (en) Chinese medicine for curing coronary disease angina pectoris
CN104666689A (en) Medicine for treating hypertension
CN103638428A (en) Traditional Chinese medicinal composition for treating coronary heart disease
CN103028094A (en) Chinese patent medicine for treating coronary heart disease
CN113679781B (en) Traditional Chinese medicine composition for treating tachyarrhythmia and preparation method and application thereof
CN107693621A (en) Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment
CN106177331A (en) A kind of Chinese medicine treating hypertension
CN105168653A (en) Traditional Chinese medicine composition used for treating coronary heart disease
CN105582280A (en) Traditional Chinese medicine preparation for treating angina pectoris of coronary heart disease
CN104740516A (en) Traditional Chinese medicine for treating coronary heart disease
CN110151922A (en) For treating the Chinese medicine composition and preparation method thereof of angina pectoris complicated hypertension disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20160330

WW01 Invention patent application withdrawn after publication